Clinical characteristics and prognostic implications in patients with HER2-low breast cancer undergoing neoadjuvant chemotherapy: a retrospective cohort study

被引：0
|
作者：
Zheng, Ang [1 ]
He, Junlin [2 ]
Li, Muyao [1 ]
Yao, Fan [1 ]
Jin, Feng [1 ]
Chen, Bo [1 ]
Wang, Xin [2 ]
机构：
[1] China Med Univ, Hosp 1, Shenyang, Peoples R China
[2] China Med Univ, Shenyang, Peoples R China
来源：
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2025年 / 55卷
关键词：
HER2; Low; Breast Cancer;
D O I：
10.1016/j.lanwpc.2024.101378
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study
    Baez-Navarro, Ximena
    van Bockstal, Mieke R.
    Jager, Agnes
    van Deurzen, Carolien H. M.
    PATHOLOGY, 2024, 56 (03) : 334 - 342
  • [2] Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapy
    Shao, Yingbo
    Guan, Huijuan
    Luo, Zhifen
    Yu, Yang
    He, Yaning
    Chen, Qi
    Liu, Chaojun
    Zhu, Fangyuan
    Liu, Hui
    BREAST, 2024, 73
  • [3] Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapy
    Shao, Yingbo
    Guan, Huijuan
    Luo, Zhifen
    Yu, Yang
    He, Yaning
    Chen, Qi
    Liu, Chaojun
    Zhu, Fangyuan
    Liu, Hui
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [4] Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant Chemotherapy
    Ma, Youzhao
    Zhu, Mingda
    Zhang, Jingyang
    Lv, Minhao
    Chen, Xiuchun
    Liu, Zhenzhen
    CANCER RESEARCH AND TREATMENT, 2023, 55 (04): : 1210 - 1221
  • [5] Analyzing Neoadjuvant Chemotherapy Effects in HER2-Low Breast Cancer: Real World Data
    Antonini, Marcelo
    Mattar, Andre
    Richter, Fernanda G.
    Ramos, Marcellus N.
    Teixeira, Marina D.
    Pantarotto, Nathalia N.
    Matta, Nadia F.
    Amorim, Andressa G.
    Pinheiro, Denise J.
    Lopes, Reginaldo C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [6] Prognostic stratification ability of the CPS plus EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy
    Roussot, Nicolas
    Constantin, Guillaume
    Desmoulins, Isabelle
    Bergeron, Anthony
    Arnould, Laurent
    Beltjens, Francoise
    Mayeur, Didier
    Kaderbhai, Coureche
    Hennequin, Audrey
    Jankowski, Clementine
    Padeano, Marie Martine
    Costaz, Helene
    Jacinto, Sarah
    Michel, Eloise
    Amet, Alix
    Coutant, Charles
    Costa, Brigitte
    Jouannaud, Christelle
    Deblock, Mathilde
    Levy, Christelle
    Ferrero, Jean -Marc.
    Kerbrat, Pierre
    Brain, Etienne
    Mouret-Reynier, Marie-Ange
    Coudert, Bruno
    Bertaut, Aurelie
    Ladoire, Sylvain
    EUROPEAN JOURNAL OF CANCER, 2024, 202
  • [7] Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy
    Ilie, Silvia Mihaela
    Briot, Nathalie
    Constantin, Guillaume
    Roussot, Nicolas
    Ilie, Alis
    Bergeron, Anthony
    Arnould, Laurent
    Beltjens, Francoise
    Desmoulin, Isabelle
    Mayeur, Didier
    Kaderbhai, Coureche
    Hennequin, Audrey
    Jankowski, Clementine
    Padeano, Marie Martine
    Costaz, Helene
    Amet, Alix
    Coutant, Charles
    Coudert, Bruno
    Bertaut, Aurelie
    Ladoire, Sylvain
    BREAST CANCER, 2023, 30 (06) : 997 - 1007
  • [8] Neoadjuvant chemotherapy ef fi cacy and prognosis in HER2-low and HER2-zero breast cancer patients by HR status: a retrospective study in China
    Zhao, Shaorong
    Wang, Yuyun
    Zhou, Angxiao
    Liu, Xu
    Zhang, Yi
    Zhang, Jin
    PEERJ, 2024, 12
  • [9] Pathological complete response and prognosis after neoadjuvant chemotherapy in patients with HER2-low breast cancer
    Qiao, Weiqiang
    Guo, Wanying
    Liu, Qipeng
    Guo, Xiao
    Deng, Miao
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 64
  • [10] HER2-low non-metastatic breast cancer in Qatar-a nationwide retrospective cohort study to evaluate the response to neoadjuvant chemotherapy: a real-world analysis
    Kardousha, Ahmed
    Shehada, Wafaa
    Basha, Ahmed
    Nasser, Sahar
    El Mistiri, Mufid
    Hamad, Anas
    Al-Bader, Salha Bujassoum
    Elazzazy, Shereen
    FRONTIERS IN ONCOLOGY, 2024, 14
12345